DEREGULATION AND POTENTIAL THERAPEUTIC TARGETING OF THE NF-κB PATHWAY IN HIGH-GRADE CHILDHOOD BRAIN TUMORS

被引：0
|
作者：
Van Vuurden, D. G. [1 ,2 ]
Hulleman, E. [2 ,3 ]
Van der Stoop, P. M. [2 ,3 ]
Gupta, R. [2 ]
Wedekind, L. E. [2 ,3 ]
Badr, C. E. [2 ,4 ,5 ,6 ]
Meijer, D. H. [2 ]
Noske, D. P. [2 ,3 ]
Wurdinger, T. [2 ,4 ,5 ,6 ]
Kaspers, G. J. L. [1 ]
Cloos, J. [1 ,7 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Ctr Canc, Neuro Oncol Res Grp, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, Amsterdam, Netherlands
[4] Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[6] Harvard Univ, Sch Med, Boston, MA 02115 USA
[7] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands
来源：
NEURO-ONCOLOGY | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：II50 / II50
页数：1
相关论文
共 50 条
  • [1] Targeting the NF-κB Pathway in Prostate Cancer: A Promising Therapeutic Approach?
    Verzella, Daniela
    Fischietti, Mariafausta
    Capece, Daria
    Vecchiotti, Davide
    Del Vecchio, Filippo
    Cicciarelli, Germana
    Mastroiaco, Valentina
    Tessitore, Alessandra
    Alesse, Edoardo
    Zazzeroni, Francesca
    CURRENT DRUG TARGETS, 2016, 17 (03) : 311 - 320
  • [2] Targeting ATR and the ERK Pathway in High-grade Solid Tumors with Concurrent NF1 and ATRX Loss
    Yuan, Ming
    Pratilas, Christine
    Blakeley, Jaishri
    Davis, Christine
    Meeker, Alan
    Heaphy, Christopher
    Rodriguez, Fausto
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 563 - 564
  • [3] Targeting brain macrophages: NF-κB as a therapeutic gateway in melanoma brain metastasis
    Molgora, Martina
    Colonna, Marco
    CANCER CELL, 2025, 43 (03) : 328 - 329
  • [4] miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma
    Yuqiong Wang
    Xiyu Zhang
    Wei Tang
    Zhenghong Lin
    Limei Xu
    Ruifen Dong
    Yinuo Li
    Jieyin Li
    Zaixin Zhang
    Xiangzhi Li
    Ling Zhao
    Jian-Jun Wei
    Changshun Shao
    Beihua Kong
    Zhaojian Liu
    Cell Death & Differentiation, 2017, 24 : 2089 - 2100
  • [5] miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma
    Wang, Yuqiong
    Zhang, Xiyu
    Tang, Wei
    Lin, Zhenghong
    Xu, Limei
    Dong, Ruifen
    Li, Yinuo
    Li, Jieyin
    Zhang, Zaixin
    Li, Xiangzhi
    Zhao, Ling
    Wei, Jian-Jun
    Shao, Changshun
    Kong, Beihua
    Liu, Zhaojian
    CELL DEATH AND DIFFERENTIATION, 2017, 24 (12): : 2089 - 2100
  • [6] Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
    Aditi S. Bapat
    Christine H. O’Connor
    Kathryn L. Schwertfeger
    Scientific Reports, 13
  • [7] Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
    Bapat, Aditi S. S.
    O'Connor, Christine H. H.
    Schwertfeger, Kathryn L. L.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Potential therapeutic targets in the NF-κB pathway for Alzheimer's disease
    Collister, KA
    Albensi, BC
    DRUG NEWS & PERSPECTIVES, 2005, 18 (10) : 623 - 629
  • [9] Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
    Yamamoto, Y
    Gaynor, RB
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (02): : 135 - 142
  • [10] NF-κB Signaling Pathway in Rheumatoid Arthritis: Mechanisms and Therapeutic Potential
    Liao, Haiyang
    Zheng, Jianxiong
    Lu, Jinyue
    Shen, Hai-li
    MOLECULAR NEUROBIOLOGY, 2024,
12345